Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Hepatitis

Free Subscription Articles published in AIDS Retrieve available abstracts of 73 articles: HTML format

Single Articles

July 2008
1. CARRAT F , Bedossa P, Lunel-Fabiani F, Morand P, et al
   Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients.
   AIDS. 2008;22:1513-5.
   PubMed     Related articles    Abstract available
   
   
   
2. SUZMAN DL , McLaughlin M, Hu Z, Kleiner DE, et al
   Identification of novel markers for liver fibrosis in HIV/hepatitis C virus coinfected individuals using genomics-based approach.
   AIDS. 2008;22:1433-9.
   PubMed     Related articles    Abstract available
   
   
   
3. SORIANO V , Puoti M, Peters M, Benhamou Y, et al
   Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.
   AIDS. 2008;22:1399-410.
   PubMed     Related articles    Abstract available
   
   
   
4. BANI-SADR F , Goderel I, Lapidus N, Driss H, et al
   Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.
   AIDS. 2008;22:1385-7.
   PubMed     Related articles   
   
   
   
5. ARENDS JE , Schrover IM, Schaar CG, Mudrikova T, et al
   Peginterferon monotherapy for the treatment of acute hepatitis C in HIV-coinfected patients.
   AIDS. 2008;22:1381-2.
   PubMed     Related articles   
   
   
   
6. NATTERMANN J , Vogel M, Nischalke HD, Danta M, et al
   The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C.
   AIDS. 2008;22:1287-92.
   PubMed     Related articles    Abstract available
   
   
   June 2008
7. BANI-SADR F , Miailhes P, Rosenthal E, Yazdanpanah Y, et al
   Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients.
   AIDS. 2008;22:1234-6.
   PubMed     Related articles   
   
   
   
8. MATSUKURA M , Chu FF, Au M, Lu H, et al
   Liver ultrastructural morphology and mitochondrial DNA levels in HIV/hepatitis C virus coinfection: no evidence of mitochondrial damage with highly active antiretroviral therapy.
   AIDS. 2008;22:1226-9.
   PubMed     Related articles    Abstract available
   
   
   
9. HARANIA RS , Karuru J, Nelson M, Stebbing J, et al
   HIV, hepatitis B and hepatitis C coinfection in Kenya.
   AIDS. 2008;22:1221-2.
   PubMed     Related articles    Abstract available
   
   
   May 2008
10. DEL VALLE J , Mira JA, de los Santos I, Lopez-Cortes LF, et al
    Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients.
    AIDS. 2008;22:923-30.
    PubMed     Related articles    Abstract available
    
    
    April 2008
11. THODEN J , Venhoff N, Miehle N, Klar M, et al
    Hepatitis E and jaundice in an HIV-positive pregnant woman.
    AIDS. 2008;22:909-10.
    PubMed     Related articles   
    
    
    
12. OLLE K , Anders S, Ola W
    Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapy.
    AIDS. 2008;22:899-901.
    PubMed     Related articles    Abstract available
    
    
    
13. NASTA P , Gatti F, Puoti M, Cologni G, et al
    Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a.
    AIDS. 2008;22:857-61.
    PubMed     Related articles    Abstract available
    
    
    
14. SORIANO V , Vispo E, Labarga P, Barreiro P, et al
    A low antiretroviral activity of the antihepatitis B drug entecavir may be enough to select for M184V in HIV-1.
    AIDS. 2008;22:911-2.
    PubMed     Related articles   
    
    
    March 2008
15. GROSS JW , Kan VL
    Trichosporon asahii infection in an advanced AIDS patient and literature review.
    AIDS. 2008;22:793-5.
    PubMed     Related articles   
    
    
    
16. FOX J , Nastouli E, Thomson E, Muir D, et al
    Increasing incidence of acute hepatitis C in individuals diagnosed with primary HIV in the United Kingdom.
    AIDS. 2008;22:666-8.
    PubMed     Related articles   
    
    
    
17. GHOSN J , Thibault V, Delaugerre C, Fontaine H, et al
    Sexually transmitted hepatitis C virus superinfection in HIV/hepatitis C virus co-infected men who have sex with men.
    AIDS. 2008;22:658-61.
    PubMed     Related articles    Abstract available
    
    
    February 2008
18. PHILLIPS E , Hayden A, Gutierrez S, Jahnke N, et al
    Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.
    AIDS. 2008;22:548-9.
    PubMed     Related articles   
    
    
    
19. STRICKLER HD , Howard AA, Peters M, Fazzari M, et al
    The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women.
    AIDS. 2008;22:527-31.
    PubMed     Related articles    Abstract available
    
    
    January 2008
20. RAFFI F , Lewden C, Chene G
    Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity.
    AIDS. 2008;22:435-6.
    PubMed     Related articles   
    
    
    
21. D'OFFIZI G , Martini F, Rozera G, Abbate I, et al
    Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
    AIDS. 2008;22:321.
    PubMed     Related articles   
    
    
    
22. GARFEIN RS
    An important, but not the first, hepatitis C virus behavioural intervention study: authors' reply.
    AIDS. 2008;22:320.
    PubMed     Related articles   
    
    
    
23. FRY CL
    An important, but not the first, hepatitis C virus behavioural intervention study.
    AIDS. 2008;22:319.
    PubMed     Related articles   
    
    
    
24. VISPO E , Martinez-Alarcon J, Poveda E, Toro C, et al
    Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user.
    AIDS. 2008;22:318.
    PubMed     Related articles   
    
    
    
25. KUNTZEN T , Tural C, Li B, Feldmann G, et al
    Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
    AIDS. 2008;22:203-10.
    PubMed     Related articles    Abstract available
    
    
    
26. NUESCH R , Ananworanich J, Srasuebkul P, Chetchotisakd P, et al
    Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection.
    AIDS. 2008;22:152-4.
    PubMed     Related articles    Abstract available
    
    
    
27. MARTIN-CARBONERO L , Nunez M, Marino A, Alcocer F, et al
    Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
    AIDS. 2008;22:15-21.
    PubMed     Related articles    Abstract available
    
    
    
28. SORIANO V , Puoti M, Garcia-Gasco P, Rockstroh JK, et al
    Antiretroviral drugs and liver injury.
    AIDS. 2008;22:1-13.
    PubMed     Related articles   
    
    
    December 2007
29. RUAN Y , Qin G, Yin L, Chen K, et al
    Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
    AIDS. 2007;21 Suppl 8:S39-46.
    PubMed     Related articles    Abstract available
    
    
    
30. ZHANG X , Wang C, Hengwei W, Li X, et al
    Risk factors of HIV infection and prevalence of co-infections among men who have sex with men in Beijing, China.
    AIDS. 2007;21 Suppl 8:S53-7.
    PubMed     Related articles    Abstract available
    
    
    
31. WU Z , Luo W, Sullivan SG, Rou K, et al
    Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.
    AIDS. 2007;21 Suppl 8:S115-22.
    PubMed     Related articles    Abstract available
    
    
    November 2007
32. LACOMBE K , Boyd A, Desvarieux M, Serfaty L, et al
    Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus.
    AIDS. 2007;21:2546-2549.
    PubMed     Related articles    Abstract available
    
    
    
33. SHASTRY L , Wilson T, Lascher S, Nord JA, et al
    The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients.
    AIDS. 2007;21:2541-2543.
    PubMed     Related articles    Abstract available
    
    
    
34. JAIN MK , Zoellner CL
    Entecavir can select for M184V of HIV-1: a case of an HIV/hepatitis B (HBV) naive patient treated for chronic HBV.
    AIDS. 2007;21:2365-6.
    PubMed     Related articles   
    
    
    
35. TUAILLON E , Tabaa YA, Baillat V, Petitjean G, et al
    Long-term persistence of memory B cells specific for hepatitis B surface antigen in HIV-1-infected patients.
    AIDS. 2007;21:2343-5.
    PubMed     Related articles    Abstract available
    
    
    
36. IZZEDINE H , M'rad MB, Bardier A, Daudon M, et al
    Atazanavir crystal nephropathy.
    AIDS. 2007;21:2357-8.
    PubMed     Related articles   
    
    
    October 2007
37. SORIANO V , Sheldon J, Garcia-Gasco P, Vispo E, et al
    Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses.
    AIDS. 2007;21:2253-4.
    PubMed     Related articles   
    
    
    
38. SULKOWSKI MS , Mehta SH, Torbenson MS, Higgins Y, et al
    Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
    AIDS. 2007;21:2209-16.
    PubMed     Related articles    Abstract available
    
    
    
39. RAFFA G , Maimone S, Cargnel A, Santantonio T, et al
    Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C.
    AIDS. 2007;21:2171-5.
    PubMed     Related articles    Abstract available
    
    
    
40. MATTHEWS GV , Hellard M, Kaldor J, Lloyd A, et al
    Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al.
    AIDS. 2007;21:2112-2113.
    PubMed     Related articles   
    
    
    
41. WYATT CM , Winston JA, Malvestutto CD, Fishbein DA, et al
    Chronic kidney disease in HIV infection: an urban epidemic.
    AIDS. 2007;21:2101-3.
    PubMed     Related articles    Abstract available
    
    
    September 2007
42. BRITO MO , Doyle T
    Movement and extrapyramidal disorders associated with interferon use in HIV/hepatitis C coinfection.
    AIDS. 2007;21:1987-9.
    PubMed     Related articles   
    
    
    
43. PAGE-SHAFER K , Hahn JA, Lum PJ
    Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough.
    AIDS. 2007;21:1967-9.
    PubMed     Related articles   
    
    
    
44. GARFEIN RS , Golub ET, Greenberg AE, Hagan H, et al
    A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users.
    AIDS. 2007;21:1923-1932.
    PubMed     Related articles    Abstract available
    
    
    
45. NEUMANN A , Polis M, Rozenberg L, Jackson J, et al
    Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.
    AIDS. 2007;21:1855-1865.
    PubMed     Related articles    Abstract available
    
    
    August 2007
46. MARINE-BARJOAN E , Berrebi A, Giordanengo V, Favre SF, et al
    HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus?
    AIDS. 2007;21:1811-1815.
    PubMed     Related articles    Abstract available
    
    
    
47. REVILL PA , Littlejohn M, Ayres A, Yuen L, et al
    Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.
    AIDS. 2007;21:1701-1710.
    PubMed     Related articles    Abstract available
    
    
    July 2007
48. NUNEZ M
    Response to Cicconi et al. 'Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?'.
    AIDS. 2007;21:1660.
    PubMed     Related articles   
    
    
    
49. BANI-SADR F , Goderel I, Morand P, Payan C, et al
    High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
    AIDS. 2007;21:1645-1648.
    PubMed     Related articles    Abstract available
    
    
    
50. MELENDEZ-MORALES L , Konkle BA, Preiss L, Zhang M, et al
    Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia.
    AIDS. 2007;21:1631-1636.
    PubMed     Related articles    Abstract available
    
    
    
51. PHILLIPS E , Gutierrez S, Jahnke N, Yip B, et al
    Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
    AIDS. 2007;21:1561-1568.
    PubMed     Related articles    Abstract available
    
    
    
52. DORE GJ , Torriani FJ, Rodriguez-Torres M, Brau N, et al
    Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection.
    AIDS. 2007;21:1555-1559.
    PubMed     Related articles    Abstract available
    
    
    
53. BJORKMAN P , Flamholc L, Molnegren V, Marshall A, et al
    Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART.
    AIDS. 2007;21:1641-1643.
    PubMed     Related articles    Abstract available
    
    
    
54. GUPTA N , Sood V, Bano AS, Banerjea AC, et al
    X Protein of hepatitis B virus potently activates HIV-1 subtype C long terminal repeat promoter: implications for faster spread of HIV-1 subtype C.
    AIDS. 2007;21:1491-2.
    PubMed     Related articles   
    
    
    
55. LONGHI E , Bestetti G, Acquaviva V, Foschi A, et al
    Human parvovirus 4 in the bone marrow of Italian patients with AIDS.
    AIDS. 2007;21:1481-3.
    PubMed     Related articles    Abstract available
    
    
    June 2007
56. WOJCIK K , Vogel M, Voigt E, Speidel N, et al
    Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort.
    AIDS. 2007;21:1363-1365.
    PubMed     Related articles    Abstract available
    
    
    
57. PIROTH L , Sene D, Pol S, Goderel I, et al
    Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY).
    AIDS. 2007;21:1323-1331.
    PubMed     Related articles    Abstract available
    
    
    
58. HOFFMANN CJ , Charalambous S, Thio CL, Martin DJ, et al
    Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B.
    AIDS. 2007;21:1301-1308.
    PubMed     Related articles    Abstract available
    
    
    
59. MOSAM A , Sathar MA, Dawood H, Cassol E, et al
    Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection.
    AIDS. 2007;21:1377-1379.
    PubMed     Related articles    Abstract available
    
    
    May 2007
60. SORIANO V , Puoti M, Sulkowski M, Cargnel A, et al
    Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.
    AIDS. 2007;21:1073-1089.
    PubMed     Related articles   
    
    
    
61. DANTA M , Brown D, Bhagani S, Pybus OG, et al
    Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours.
    AIDS. 2007;21:983-991.
    PubMed     Related articles    Abstract available
    
    
    April 2007
62. UNZURRUNZAGA A , Martinez E, Miguelez JL, Cazallas J, et al
    Partial splenic embolization as a treatment for hypersplenism in HIV/hepatitis C virus-co-infected patients.
    AIDS. 2007;21:885-7.
    PubMed     Related articles   
    
    
    March 2007
63. MATTHEWS GV , Dore GJ
    Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'
    AIDS. 2007;21:777-778.
    PubMed     Related articles   
    
    
    
64. ROUPHAEL NG , Talati NJ, Rimland D
    Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature.
    AIDS. 2007;21:771-4.
    PubMed     Related articles    Abstract available
    
    
    
65. PAUL S , Javed U, Tevendale R, Lanford J, et al
    Acquired factor VIII inhibitor in an HIV-infected patient after treatment with pegylated interferon-alpha 2a and ribavirin.
    AIDS. 2007;21:784-5.
    PubMed     Related articles   
    
    
    
66. RAMOS B , Sheldon J, Ruiz-Sancho A, Toro C, et al
    Prevalence and therapeutic significance of anti-interferon antibodies in hepatitis C virus/HIV-co-infected patients.
    AIDS. 2007;21:652-3.
    PubMed     Related articles   
    
    
    
67. HOWARD AA , Lo Y, Floris-Moore M, Klein RS, et al
    Hepatitis C virus infection is associated with insulin resistance among older adults with or at risk of HIV infection.
    AIDS. 2007;21:633-41.
    PubMed     Related articles    Abstract available
    
    
    
68. CICCONI P , Cozzi-Lepri A, Phillips A, Puoti M, et al
    Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
    AIDS. 2007;21:599-606.
    PubMed     Related articles    Abstract available
    
    
    
69. DE MENDOZA C , Martin-Carbonero L, Barreiro P, de Baar M, et al
    Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy.
    AIDS. 2007;21:583-8.
    PubMed     Related articles    Abstract available
    
    
    February 2007
70. CRESPO M , Esteban JI, Ribera E, Falco V, et al
    Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients.
    AIDS. 2007;21:477-481.
    PubMed     Related articles    Abstract available
    
    
    
71. IZZEDINE H , Deray G
    The nephrologist in the HAART era.
    AIDS. 2007;21:409-21.
    PubMed     Related articles   
    
    
    January 2007
72. CHAKVETADZE C , Bani-Sadr F, Pendeven CL, Lamontagne F, et al
    Reactivation of hepatitis B virus replication during peginterferon-ribavirin therapy in an HIV/hepatitis C virus-co-infected patient with isolated anti-hepatitis B core antibodies.
    AIDS. 2007;21:393-4.
    PubMed     Related articles   
    
    
    
73. PAVEL S , Burty C, Alcaraz I, de la Tribonniere X, et al
    Severe liver toxicity in postexposure prophylaxis for HIV infection with a zidovudine, lamivudine and fosamprenavir/ritonavir regimen.
    AIDS. 2007;21:268-269.
    PubMed     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: